CEFUROXIME AXETIL- cefuroxime axetil tablet United States - English - NLM (National Library of Medicine)

cefuroxime axetil- cefuroxime axetil tablet

a-s medication solutions - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 250 mg - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes. limitations of use - the efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. - the efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae , haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bacte

CEFUROXIME AXETIL tablet, film coated United States - English - NLM (National Library of Medicine)

cefuroxime axetil tablet, film coated

a-s medication solutions - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 250 mg - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use - the efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. -  the efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae, haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute ba

Cefuroxime 1.5 g powder for solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

cefuroxime 1.5 g powder for solution for injection/infusion

fresenius kabi deutschland gmbh - cefuroxime sodium - powder for solution for injection/infusion - 1.5 gram(s) - second-generation cephalosporins; cefuroxime

Cefuroxime EG 500 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefuroxime eg 500 mg film-coat. tabl.

eg sa-nv - cefuroxime axetil 601,44 mg - eq. cefuroxime 500 mg - film-coated tablet - 500 mg - cefuroxime axetil 601.44 mg - cefuroxime

Cefuroxime Stravencon 250 mg inf. sol. (pwdr.) i.m./i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefuroxime stravencon 250 mg inf. sol. (pwdr.) i.m./i.v. vial

stravencon ltd. - cefuroxime sodium - eq. cefuroxime 250 mg - powder for solution for infusion - 250 mg - cefuroxime sodium - cefuroxime

Cefuroxime Stravencon 750 mg inf. sol. (pwdr.) i.m./i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefuroxime stravencon 750 mg inf. sol. (pwdr.) i.m./i.v. vial

stravencon ltd. - cefuroxime sodium - eq. cefuroxime 750 mg - powder for solution for infusion - 750 mg - cefuroxime sodium - cefuroxime

Cefuroxime Stravencon 1500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cefuroxime stravencon 1500 mg inj./inf. sol. (pwdr.) i.m./i.v. vial

stravencon ltd. - cefuroxime sodium - eq. cefuroxime 1500 mg - powder for solution for injection/infusion - 1500 mg - cefuroxime sodium - cefuroxime

CEFUROXIME BE PHARMA 750 MG Israel - English - Ministry of Health

cefuroxime be pharma 750 mg

a.l. medi-market ltd. - cefuroxime as sodium - powder for solution or suspension for injection or infusion - cefuroxime as sodium 750 mg/vial - cefuroxime - cefuroxime be pharma 750 mg is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth)•community acquired pneumonia•acute exacerbations of chronic bronchitis•complicated urinary tract infections, including pyelonephritis•soft-tissue infections: cellulitis, erysipelas and wound infections•intra-abdominal infections•prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section)•nose infections for example, sinusitis•septic arthritis

NOVO-CEFUROXIME TABLET Canada - English - Health Canada

novo-cefuroxime tablet

novopharm limited - cefuroxime (cefuroxime axetil) - tablet - 125mg - cefuroxime (cefuroxime axetil) 125mg - second generation cephalosporins